InequalityOpen ScienceBig PharmaCOVID VaccinesDrug PatentsEconomía y EmpresaInglésThe Quant Case for Open-Access COVID Vaccineshttps://doi.org/10.59350/p8t30-2rw41Publicado 9 de junio de 2021Autor Blair FixExportarCitaI crunch the numbers on COVID vaccines. No surprises … they’re going overwhelmingly to rich countries.